{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T17:06:16Z","timestamp":1784221576366,"version":"3.55.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biotechnology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.jbiotec.2023.07.001","type":"journal-article","created":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T02:10:14Z","timestamp":1688609414000},"page":"42-48","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Cytotoxic and apoptotic effects of chemically synthesized silver nanoparticles loaded with recombinant Staphylococcus LukS-PV toxin"],"prefix":"10.1016","volume":"373","author":[{"given":"Hafizeh","family":"Haghighatafshar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahram","family":"Golestani Eimani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Moazamian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jafar","family":"Amani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jbiotec.2023.07.001_bib1","first-page":"43","article-title":"On the anti-cancer activities of silver nanoparticles","volume":"5","author":"Abdel-Fattah","year":"2018","journal-title":"J. Appl. Biotechnol. Bioeng."},{"issue":"1","key":"10.1016\/j.jbiotec.2023.07.001_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/073911010010524952","article-title":"Structural model of the pre-pore ring-like structure of Panton-Valentine leukocidin: providing dimensionality to biophysical and mutational data","volume":"28","author":"Aman","year":"2010","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.jbiotec.2023.07.001_bib3","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.imlet.2017.07.015","article-title":"Nanoparticles and targeted drug delivery in cancer therapy","volume":"190","author":"Bahrami","year":"2017","journal-title":"Immunol. Lett."},{"issue":"2","key":"10.1016\/j.jbiotec.2023.07.001_bib4","doi-asserted-by":"crossref","first-page":"891","DOI":"10.7314\/APJCP.2013.14.2.891","article-title":"Effect of botulinum toxin A on proliferation and apoptosis in the T47D breast cancer cell line","volume":"14","author":"Bandala","year":"2013","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.jbiotec.2023.07.001_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2020.100671","article-title":"Unraveling survivin expression in chronic myeloid leukemia: Molecular interactions and clinical implications","author":"Bernardo","year":"2020","journal-title":"Blood Rev."},{"issue":"8","key":"10.1016\/j.jbiotec.2023.07.001_bib6","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/j.biocel.2013.05.011","article-title":"LukS-PV induces mitochondrial-mediated apoptosis and G0\/G1 cell cycle arrest in human acute myeloid leukemia THP-1 cells","volume":"45","author":"Bu","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"9","key":"10.1016\/j.jbiotec.2023.07.001_bib7","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3390\/nano8090681","article-title":"Biomedical applications of silver nanoparticles: an up-to-date overview","volume":"8","author":"Burdu\u0219el","year":"2018","journal-title":"Nanomaterials"},{"key":"10.1016\/j.jbiotec.2023.07.001_bib8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.biocel.2016.04.005","article-title":"LukS-PV induces differentiation by activating the ERK signaling pathway and c-JUN\/c-FOS in human acute myeloid leukemia cells","volume":"76","author":"Dai","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"2","key":"10.1016\/j.jbiotec.2023.07.001_bib9","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4103\/AIHB.AIHB_69_20","article-title":"Bacterial protein azurin and tumour suppressor p53 in cancer regression","volume":"11","author":"Dharmawickreme","year":"2021","journal-title":"Adv. Hum. Biol."},{"key":"10.1016\/j.jbiotec.2023.07.001_bib10","doi-asserted-by":"crossref","first-page":"7291","DOI":"10.2147\/IJN.S146315","article-title":"Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors","volume":"12","author":"Din","year":"2017","journal-title":"Int. J. Nanomed."},{"issue":"9","key":"10.1016\/j.jbiotec.2023.07.001_bib11","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.3390\/biomedicines9091194","article-title":"The azurin-derived peptide ct-p19lc exhibits membrane-active properties and induces cancer cell death","volume":"9","author":"Garizo","year":"2021","journal-title":"Biomedicines"},{"issue":"9","key":"10.1016\/j.jbiotec.2023.07.001_bib12","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1080\/17458080.2016.1139196","article-title":"Synthesis of silver nanoparticles by chemical and biological methods and their antimicrobial properties","volume":"11","author":"Gudikandula","year":"2016","journal-title":"J. Exp. Nanosci."},{"issue":"1","key":"10.1016\/j.jbiotec.2023.07.001_bib13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13568-023-01558-3","article-title":"The anticancer effect of recombinant LukS-PV protein and silver nanoparticles loaded with this protein","volume":"13","author":"Haghighatafshar","year":"2023","journal-title":"AMB Express"},{"key":"10.1016\/j.jbiotec.2023.07.001_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2021.111888","article-title":"Antibacterial efficacy of facile cyanobacterial silver nanoparticles inferred by antioxidant mechanism","volume":"122","author":"Husain","year":"2021","journal-title":"Mater. Sci. Eng.: C."},{"key":"10.1016\/j.jbiotec.2023.07.001_bib15","first-page":"1","article-title":"Novel drug delivery systems based on silver nanoparticles, hyaluronic acid, lipid nanoparticles and liposomes for cancer treatment","author":"Hussein","year":"2021","journal-title":"Appl. Nanosci."},{"issue":"1","key":"10.1016\/j.jbiotec.2023.07.001_bib16","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ajh.24249","article-title":"Chronic myeloid leukemia: first\u2010line drug of choice","volume":"91","author":"Jabbour","year":"2016","journal-title":"Am. J. Hematol."},{"issue":"3","key":"10.1016\/j.jbiotec.2023.07.001_bib17","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/ajh.25011","article-title":"Chronic myeloid leukemia: 2018 update on diagnosis, therapy and monitoring","volume":"93","author":"Jabbour","year":"2018","journal-title":"Am. J. Hematol."},{"issue":"6","key":"10.1016\/j.jbiotec.2023.07.001_bib18","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/ajh.25792","article-title":"Chronic myeloid leukemia: 2020 update on diagnosis, therapy and monitoring","volume":"95","author":"Jabbour","year":"2020","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.jbiotec.2023.07.001_bib19","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/9781119252863.ch6","article-title":"Chronic myeloid leukemia","author":"Kantarjian","year":"2019","journal-title":"Mol. Hematol."},{"issue":"2","key":"10.1016\/j.jbiotec.2023.07.001_bib20","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3390\/pharmaceutics10020054","article-title":"Anticancer activity of bacterial proteins and peptides","volume":"10","author":"Karpi\u0144ski","year":"2018","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.jbiotec.2023.07.001_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13058-015-0576-1","article-title":"Efficient treatment of breast cancer xenografts with multifunctionalized iron oxide nanoparticles combining magnetic hyperthermia and anti-cancer drug delivery","volume":"17","author":"Kossatz","year":"2015","journal-title":"Breast Cancer Res."},{"issue":"2","key":"10.1016\/j.jbiotec.2023.07.001_bib22","doi-asserted-by":"crossref","first-page":"839","DOI":"10.3390\/ijms23020839","article-title":"Cancer therapy by silver nanoparticles: fiction or reality?","volume":"23","author":"Kov\u00e1cs","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbiotec.2023.07.001_bib23","first-page":"1","article-title":"Transport and metabolism of tyrosine kinase inhibitors associated with chronic myeloid leukemia therapy: A review","author":"Kumar","year":"2022","journal-title":"Mol. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.jbiotec.2023.07.001_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2022.05.032","article-title":"Advances of nanoparticles as drug delivery systems for disease diagnosis and treatment","volume":"34","author":"Liu","year":"2023","journal-title":"Chin. Chem. Lett."},{"issue":"1","key":"10.1016\/j.jbiotec.2023.07.001_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40580-019-0193-2","article-title":"Current trends and challenges in cancer management and therapy using designer nanomaterials","volume":"6","author":"Navya","year":"2019","journal-title":"Nano Converg."},{"key":"10.1016\/j.jbiotec.2023.07.001_bib26","series-title":"Pet-To-Man Travelling Staphylococci","first-page":"117","article-title":"The Staphylococcal Panton-Valentine leukocidin (PVL)","author":"Nawrotek","year":"2018"},{"key":"10.1016\/j.jbiotec.2023.07.001_bib27","first-page":"2249","article-title":"Nanoparticle\u2013biological interactions: the renaissance of bionomics in the myriad nanomedical technologies","author":"Panda","year":"2021","journal-title":"Future Med."},{"issue":"3","key":"10.1016\/j.jbiotec.2023.07.001_bib28","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1039\/D1GC04103G","article-title":"Molecular nanoinformatics approach assessing the biocompatibility of biogenic silver nanoparticles with channelized intrinsic steatosis and apoptosis","volume":"24","author":"Panda","year":"2022","journal-title":"Green. Chem."},{"issue":"2","key":"10.1016\/j.jbiotec.2023.07.001_bib29","first-page":"135","article-title":"Botulinum Toxin Type-A Toxinactivity in Prostate Cancer Cell Lines. Urologia","volume":"79","author":"Proietti","year":"2012","journal-title":"Journal"},{"issue":"4","key":"10.1016\/j.jbiotec.2023.07.001_bib30","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0161-813X(01)00042-0","article-title":"Clostridium botulinum neurotoxins act with a wide range of potencies on SH-SY5Y human neuroblastoma cells","volume":"22","author":"Purkiss","year":"2001","journal-title":"Neurotoxicology"},{"issue":"4","key":"10.1016\/j.jbiotec.2023.07.001_bib31","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.bbrc.2019.10.181","article-title":"LukS-PV induces cell cycle arrest and apoptosis through p38\/ERK MAPK signaling pathway in NSCLC cells","volume":"521","author":"Qiang","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.jbiotec.2023.07.001_bib32","doi-asserted-by":"crossref","first-page":"855","DOI":"10.3390\/cancers12040855","article-title":"Green chemistry synthesis of silver nanoparticles and their potential anticancer effects","volume":"12","author":"Ratan","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.jbiotec.2023.07.001_bib33","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1371\/journal.pone.0024012","article-title":"Synergistic anticancer effects of the 9.2. 27PE immunotoxin and ABT-737 in melanoma","volume":"6","author":"Risberg","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.jbiotec.2023.07.001_bib34","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.biocel.2015.01.007","article-title":"LukS-PV, a component of Panton-Valentine leukocidin, exerts potent activity against acute myeloid leukemia in vitro and in vivo","volume":"61","author":"Shan","year":"2015","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.jbiotec.2023.07.001_bib35","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.gene.2016.11.044","article-title":"Is LukS-PV a novel experimental therapy for leukemia?","volume":"600","author":"Shan","year":"2017","journal-title":"Gene"},{"issue":"5","key":"10.1016\/j.jbiotec.2023.07.001_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/br.2021.1418","article-title":"Nanotechnology and its use in imaging and drug delivery","volume":"14","author":"Sim","year":"2021","journal-title":"Biomed. Rep."},{"key":"10.1016\/j.jbiotec.2023.07.001_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.mtbio.2022.100463","article-title":"The translational paradigm of nanobiomaterials: Biological chemistry to modern applications","author":"Sinha","year":"2022","journal-title":"Mater. Today Bio"},{"issue":"1","key":"10.1016\/j.jbiotec.2023.07.001_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-017-0308-z","article-title":"Metal nanoparticles: understanding the mechanisms behind antibacterial activity","volume":"15","author":"Slavin","year":"2017","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.jbiotec.2023.07.001_bib39","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1158\/1535-7163.MCT-20-0336","article-title":"HLA polymorphisms are associated with treatment-free remission following discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia","volume":"20","author":"Ureshino","year":"2021","journal-title":"Mol. Cancer Ther."},{"issue":"9","key":"10.1016\/j.jbiotec.2023.07.001_bib40","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1039\/D1GC00571E","article-title":"Determining factors for the nano-biocompatibility of cobalt oxide nanoparticles: proximal discrepancy in intrinsic atomic interactions at differential vicinage","volume":"23","author":"Verma","year":"2021","journal-title":"Green. Chem."},{"issue":"10","key":"10.1016\/j.jbiotec.2023.07.001_bib41","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1158\/1535-7163.MCT-11-0206","article-title":"Targeting tumor-initiating cancer cells with dCD133KDEL shows impressive tumor reductions in a xenotransplant model of human head and neck cancer","volume":"10","author":"Waldron","year":"2011","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jbiotec.2023.07.001_bib42","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.omto.2020.05.006","article-title":"LukS-PV inhibits hepatocellular carcinoma progression by downregulating HDAC2 expression","volume":"17","author":"Wang","year":"2020","journal-title":"Mol. Ther. -Oncolytics"},{"key":"10.1016\/j.jbiotec.2023.07.001_bib43","first-page":"4149","article-title":"LukS-PV Induces Apoptosis via the SET8-H4K20me1-PIK3CB Axis in Human Acute Myeloid Leukemia Cells","author":"Xu","year":"2021","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.jbiotec.2023.07.001_bib44","first-page":"37","article-title":"Chemical synthesis of silver nanoparticles using tri-sodium citrate, stability study and their characterization. International Research Journal of Pure and Applied Chemistry","volume":"21","author":"Yerragopu","year":"2020"},{"issue":"5","key":"10.1016\/j.jbiotec.2023.07.001_bib45","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1002\/cam4.2137","article-title":"LukS\u2010PV induces apoptosis in acute myeloid leukemia cells mediated by C5a receptor","volume":"8","author":"Zhang","year":"2019","journal-title":"Cancer Med."},{"key":"10.1016\/j.jbiotec.2023.07.001_bib46","unstructured":"Zhang Y., Wu X., Sun X., Yang J., Liu C., Tang G., et al. Advances in Development of Drugs for Chronic Myelogenous Leukemia. Mini Reviews in Medicinal Chemistry, 2022."}],"container-title":["Journal of Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168165623001293?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168165623001293?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T13:01:16Z","timestamp":1759150876000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168165623001293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":46,"alternative-id":["S0168165623001293"],"URL":"https:\/\/doi.org\/10.1016\/j.jbiotec.2023.07.001","relation":{},"ISSN":["0168-1656"],"issn-type":[{"value":"0168-1656","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytotoxic and apoptotic effects of chemically synthesized silver nanoparticles loaded with recombinant Staphylococcus LukS-PV toxin","name":"articletitle","label":"Article Title"},{"value":"Journal of Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbiotec.2023.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}